Total Payments
$3,943
2024 Payments
$1,225
Companies
31
Transactions
167
Medicare Patients
4,230
Medicare Billing
$204,320
Payment Breakdown by Category
Food & Beverage$3,854 (97.7%)
Education$89.00 (2.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,854 | 166 | 97.7% |
| Education | $89.00 | 1 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $560.03 | 22 | $0 (2024) |
| Janssen Biotech, Inc. | $333.71 | 15 | $0 (2024) |
| Teleflex LLC | $310.18 | 5 | $0 (2024) |
| ABBVIE INC. | $307.32 | 15 | $0 (2024) |
| PFIZER INC. | $277.41 | 13 | $0 (2024) |
| Myovant Sciences Inc. | $275.63 | 13 | $0 (2022) |
| Astellas Pharma US Inc | $186.21 | 9 | $0 (2024) |
| PROGENICS PHARMACEUTICALS, INC. | $181.22 | 4 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $172.84 | 7 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $149.82 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,225 | 50 | Bayer Healthcare Pharmaceuticals Inc. ($234.43) |
| 2023 | $1,041 | 43 | Janssen Biotech, Inc. ($198.47) |
| 2022 | $1,107 | 47 | Myovant Sciences Inc. ($150.71) |
| 2021 | $570.69 | 27 | PFIZER INC. ($139.13) |
All Payment Transactions
167 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/11/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $28.16 | General |
| Category: Oncology | ||||||
| 11/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: UROLOGY | ||||||
| 11/01/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $34.33 | General |
| Category: Oncology | ||||||
| 10/17/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $29.37 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 10/16/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Oncology | ||||||
| 09/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: UROLOGY | ||||||
| 09/23/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/20/2024 | Calyxo, Inc. | CVAC ASPIRATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: Urology | ||||||
| 09/19/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: ONCOLOGY | ||||||
| 09/19/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Oncology | ||||||
| 09/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $27.62 | General |
| Category: Oncology | ||||||
| 08/27/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/23/2024 | Boston Scientific Corporation | AMS 700 (Device) | Food and Beverage | In-kind items and services | $35.44 | General |
| Category: AMS 700_URO | ||||||
| 08/14/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: UROLOGY | ||||||
| 08/09/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: ONCOLOGY | ||||||
| 08/08/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: ONCOLOGY | ||||||
| 07/24/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 07/17/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $17.28 | General |
| Category: Prostate cancer | ||||||
| 06/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Oncology | ||||||
| 06/26/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 06/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $2.88 | General |
| Category: UROLOGY | ||||||
| 06/19/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 908 | 1,146 | $159,570 | $34,749 |
| 2022 | 9 | 1,091 | 1,447 | $208,797 | $48,013 |
| 2021 | 16 | 1,618 | 2,357 | $370,301 | $98,064 |
| 2020 | 7 | 613 | 790 | $75,939 | $23,494 |
Total Patients
4,230
Total Services
5,740
Medicare Billing
$204,320
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 206 | 257 | $77,100 | $18,241 | 23.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 113 | 138 | $27,600 | $6,799 | 24.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $18,450 | $4,174 | 22.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 185 | 231 | $13,860 | $1,584 | 11.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 31 | 33 | $6,600 | $1,571 | 23.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $6,000 | $1,193 | 19.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 296 | 408 | $8,160 | $897.60 | 11.0% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 16 | 18 | $1,800 | $289.95 | 16.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 322 | 467 | $130,390 | $30,823 | 23.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 60 | 60 | $23,220 | $5,494 | 23.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 75 | 94 | $17,120 | $4,618 | 27.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 40 | 43 | $7,600 | $2,467 | 32.5% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 163 | 203 | $11,695 | $1,362 | 11.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 11 | $4,190 | $1,270 | 30.3% |
| 81003 | Automated urinalysis test | Office | 2022 | 358 | 497 | $9,390 | $1,098 | 11.7% |
| 74018 | X-ray of abdomen, 1 view | Office | 2022 | 44 | 53 | $4,850 | $820.41 | 16.9% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2022 | 18 | 19 | $342.00 | $60.11 | 17.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 479 | 851 | $161,690 | $59,513 | 36.8% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2021 | 13 | 45 | $58,500 | $7,528 | 12.9% |
| 51728 | Complex measurement of pressure of urine flow in bladder (cystometrogram) with voiding pressure studies | Office | 2021 | 34 | 34 | $21,080 | $7,264 | 34.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 75 | 75 | $23,250 | $6,901 | 29.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 61 | 90 | $10,800 | $4,377 | 40.5% |
| 51797 | Insertion of device into the abdomen with measurement of pressure and urine flow rate | Office | 2021 | 34 | 34 | $24,820 | $3,805 | 15.3% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2021 | 264 | 371 | $20,405 | $2,242 | 11.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 16 | 16 | $5,760 | $2,095 | 36.4% |
About Jay Rains
Jay Rains is a Physician Assistant healthcare provider based in Athens, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/01/2018. The National Provider Identifier (NPI) number assigned to this provider is 1043718331.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jay Rains has received a total of $3,943 in payments from pharmaceutical and medical device companies, with $1,225 received in 2024. These payments were reported across 167 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($3,854).
As a Medicare-enrolled provider, Rains has provided services to 4,230 Medicare beneficiaries, totaling 5,740 services with total Medicare billing of $204,320. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Athens, GA
- Active Since 02/01/2018
- Last Updated 04/25/2018
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1043718331
Products in Payments
- Nubeqa (Drug) $560.03
- ORGOVYX (Drug) $448.47
- ERLEADA (Drug) $378.68
- XTANDI (Drug) $320.63
- UROLIFT (Device) $310.18
- BOTOX (Biological) $202.33
- ELIGARD (Drug) $186.80
- PYLARIFY (Drug) $181.22
- XYOSTED (Drug) $159.43
- PROVENGE (Drug) $149.82
- Prolaris (Device) $118.59
- Xtandi (Drug) $106.71
- LUPRON DEPOT (Drug) $104.99
- ADSTILADRIN (Biological) $87.78
- Axumin (Drug) $79.32
- XIAFLEX (Biological) $65.16
- Seglentis (Drug) $39.31
- Myrbetriq (Drug) $36.28
- YONSA (Drug) $35.99
- AMS 700 (Device) $35.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Athens
Kirk Gautier, Pac, PAC
Physician Assistant — Payments: $301,906
Physician Assistant $301,906
Simon Bessette, Pa-C, PA-C
Physician Assistant — Payments: $21,534
Physician Assistant $21,534
Adriana Walsh, Pa-C, PA-C
Physician Assistant — Payments: $11,402
Physician Assistant $11,402
William Retterbush, Pa-C, PA-C
Physician Assistant — Payments: $7,302
Physician Assistant $7,302
Sebastian Afonso, Pac, PAC
Physician Assistant — Payments: $6,987
Physician Assistant $6,987
Ms. Miranda Seagraves, Pa-C, PA-C
Physician Assistant — Payments: $6,563
Physician Assistant $6,563